Dissecting cell-type-specific metabolism in pancreatic ductal adenocarcinoma

Authors:

Abstract
Tumors are composed of many different cell types including cancer cells, fibroblasts, and immune cells. Dissecting functional metabolic differences between cell types within a mixed population can be challenging due to the rapid turnover of metabolites relative to the time needed to isolate cells. To overcome this challenge, we traced isotope-labeled nutrients into macromolecules that turn over more slowly than metabolites. This approach was used to assess differences between cancer cell and fibroblast metabolism in murine pancreatic cancer organoid-fibroblast co-cultures and tumors. Pancreatic cancer cells exhibited increased pyruvate carboxylation relative to fibroblasts, and this flux depended on both pyruvate carboxylase and malic enzyme 1 activity. Consequently, expression of both enzymes in cancer cells was necessary for organoid and tumor growth, demonstrating that dissecting the metabolism of specific cell populations within heterogeneous systems can identify dependencies that may not be evident from studying isolated cells in culture or bulk tissue.
All Related Versions
Funding Information
  • Damon Runyon Cancer Research Foundation (DRG-2241-15)
  • Damon Runyon Cancer Research Foundation (DRG-2367-19)
  • Damon Runyon Cancer Research Foundation (DRG-2299-17)
  • National Cancer Institute (K99CA234221)
  • National Institutes of Health (T32GM007287)
  • Jane Coffin Childs Memorial Fund for Medical Research
  • Swedish Foundation for Strategic Research
  • Knut and Alice Wallenberg Foundation
  • Barbro Osher Pro Suecia Foundation
  • National Cancer Institute (U54CA163109)
  • Human Frontier Science Program (LT000195/2015-L)
  • EMBO (ALTF 1203-2014)
  • Howard Hughes Medical Institute
  • MRC (CSF MR/P008801/1)
  • NHSBT (WPA15-02)
  • NIHR Cambridge BRC
  • National Institutes of Health (R01CA211184)
  • National Institutes of Health (R01CA034992)
  • Lustgarten Foundation
  • Stand Up To Cancer
  • MIT Center for Precision Cancer Medicine
  • Ludwig Center at MIT
  • Emerald Foundation
  • National Cancer Institute (R01CA168653)
  • National Cancer Institute (R01CA201276)
  • National Cancer Institute (R35CA242379)
  • National Cancer Institute (P30CA14051)

This publication has 99 references indexed in Scilit: